Weapon against tumors, boost for the immune system

Radiation therapy is a proven approach to destroying tumours. However, it is possible that it might be able to do even more in the future — namely stimulate the immune system at the same time and so fight cancer even more intensively. The foundations for this have been laid by researchers led by TU Darmstadt. They have found that x-rays trigger a calcium signalling cascade in cells of the immune system. The results have now been published in the Journal of General Physiology.
Ionising radiation is successfully used in cancer treatment to kill tumour cells. Over the past two decades, it has become clear that treatment success can be increased even further if the radiation treatment is combined with measures to stimulate the immune system. In this context, a new study being carried out with biologists from TU Darmstadt and the GSI Helmholtz Centre for Heavy Ion Research plus researchers from the clinics of the Frankfurt and Homburg universities is attracting attention. The researchers report in the Journal of General Physiology that the desired stimulating effect on the immune system is triggered directly when T-cells are also irradiated by x-rays. Dominique Tandl, researcher at the Department of Biology at TU Darmstadt, and her co-authors demonstrate in the recently published study that clinically relevant doses of x-rays in T lymphocytes trigger a signalling cascade that is typical of the immune reaction that begins with the release of the messenger substance calcium (Ca2+) from internal stores.
Activated by what is known as store operated Ca2+ entry (SOCE), the concentration of Ca2+ in the cells begins to oscillate at a critical frequency, which in turn leads to the displacement (translocation) of a transcription factor from the cytoplasm into the cell nucleus. Once there, this transcription factor initiates gene expression, and the cell begins to make molecules that are important for the immune response, such as cytokines. Since the irradiation of tumours invariably always affects the blood cells in the target tissue, medicine could utilise the stimulating effect of x-rays on T lymphocytes. The researchers hope that their studies will contribute to improving cancer treatment in the long term, as Professor Gerhard Thiel, head of the Membrane Biophysics Group at the Department of Biology at TU Darmstadt and co-author of the study, says. “It could be possible to enhance the killing effect of ionising radiation on tumour cells and at the same time to stimulate the immune system with the help of this radiation.”
Story Source:
Materials provided by Technische Universitat Darmstadt. Note: Content may be edited for style and length.

Read more →

Cellular diversity of esophageal tissue revealed

In a study published today in the journal Nature Communications, researchers at the Lewis Katz School of Medicine at Temple University defined 11 subsets of cells found in the esophagus of mice, information that could potentially help clinicians diagnose or treat certain types of cancer.
The tissue in the esophagus — known as stratified squamous epithelium — is composed of a basal layer that ultimately gives rise to several layers of differentiated cells. In this study, researchers sought to find out whether basal cells were all the same or if any differences existed in their gene expressions.
“This work lays the foundation to address questions about how these cells relate to the development of cancer,” said Kelly Whelan, PhD, senior author on the study and Assistant Professor of Cancer and Cellular Biology and Assistant Professor in the Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine.
“The next question we have is if we give a mouse a carcinogen, does one particular subset expand or is another particular subset depleted? If so, we would want to know whether cell types that change in the context of cancer are functionally contributing to the cancer process and whether we can target them to help treat or prevent cancer,” she said.
To begin to address these questions, Whelan and her fellow researchers used single cell gene-expression profiling, a tool that identifies all the genes in a cell or tissue that make messenger RNA. These profiles can then be used to identify individual cell types within a complex tissue.
“Essentially, we took more than 40,000 cells from mouse esophageal epithelium and used their individual gene-expression profiles to group them based on their commonality,” she said.
When they started the study, Whelan said the researchers expected to find about three subsets of cells classified as basal, but they actually found six subsets, as well as four that were classified as differentiated. Additionally, one cell type was found to have characteristics of both basal and differentiated cells and was defined as an intermediate cell type.
“We are now working to isolate these individual cell types in order to determine what the cells do functionally in terms of esophageal biology in the normal context first and then in the context of cancer. This study is a fundamental step toward that,” said Whelan.
Story Source:
Materials provided by Temple University Health System. Note: Content may be edited for style and length.

Read more →

Gastric inflammation: How a bacterial infection causes tissue changes

When the bacterium Helicobacter pylori infects the stomach, it causes gastric inflammation and increases the risk of stomach cancer. A team of researchers from Charité — Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) have been able to elucidate characteristic changes which occur inside the gastric glands during an H. pylori infection. The researchers discovered a novel mechanism which, by restricting cell division in healthy stomach tissue, protects the stomach against cancerous changes. An inflammation of the stomach, however, deactivates this mechanism, enabling cells to grow in an uncontrolled manner. The researchers’ findings, which have been published in Nature Communications, may herald a new treatment target in stomach cancer.
Affecting about half the world’s population, Helicobacter pylori is one of the most common causes of chronic bacterial infections in humans. H. pylori can lead to inflammation of the stomach (gastritis) and increase the risk of developing stomach cancer. As the protective lining inside the stomach is constantly exposed to stomach acid, it has to regenerate completely every few weeks, while maintaining both its structure and composition despite the high cellular turnover. “Until now, researchers had assumed that a Helicobacter infection causes direct damage to the gastric gland cells in the stomach lining and that gastric pathology upon infection is simply the result of this process,” explains the study’s last author, Prof. Dr. Michael Sigal. He continues: “In fact, our team has now discovered that the infection disrupts complex interactions between different cell types and signals which are responsible for tissue stability.” Prof. Sigal is Professor for Translational Gastrointestinal Oncology and leads an Independent Research Group at Charité’s Department of Hepatology and Gastroenterology and the Berlin Institute for Medical Systems Biology (BIMSB), which forms part of the MDC.
Led by Prof. Sigal and working alongside colleagues from the Max Planck Institute for Infection Biology, the team of researchers used complex mouse models to observe changes occurring inside the gastric glands. Using state-of-the art imaging and single-cell sequencing technologies, the researchers were able to visualize and isolate specific gastric gland cells, which they then examined in detail. In order to minimize the need for animal models, they also developed special organ-like tissue microstructures known as organoids. The researchers used these microscopic stomachs to recreate many of the gastric glands’ characteristics. This strategy enabled them to study the effects of various signals on stem cells which are found inside the gastric glands (and which are capable of differentiating into many different cell types).
“We discovered that ‘stromal cells’ — a type of cell surrounding the gastric glands — are not only responsible for mechanical stability of the glands, as previously thought. Instead, they produce various signaling molecules which significantly influence the behavior of the gland cells,” explains Prof. Sigal. These substances include ‘bone morphogenetic proteins’ (BMPs), which play an important role in tissue development. The researchers were able to show that stromal cells surrounding the gland base continually inhibit the BMP signaling pathway, thereby stimulating the proliferation of nearby stem cells. In contrast, stromal cells at the gland surface were found to activate the signaling pathway, thereby suppressing cell proliferation. Together, this forms a signaling gradient that guides stem cell turnover and differentiation, and serves as the basis for the gland’s structural stability. Helicobacter infection causes the release of pro-inflammatory substances such as interferon-gamma (IFN-γ). This inflammatory cytokine interferes with the BMP signaling axis, resulting in less BMP signaling activity and stimulating gland stem cell proliferation. This results in hyperplasia, a precancerous lesion characterized by tissue enlargement.
“Our findings show that an infection-driven inflammatory response has far more pronounced effects than previously thought. In addition to their well-characterized antimicrobial effects, pro-inflammatory substances such as IFN-γ affect both cell proliferation and tissue stem cell behavior and therefore have a direct impact on tissue homeostasis. In the case of tissue damage, increased cell proliferation can be useful, as it promotes rapid healing. In the case of chronic inflammation associated with a Helicobacter infection, however, it could facilitate the development of precancerous lesions,” summarizes Prof. Sigal. The signaling pathways governing interactions between the immune system and stem cells in the stomach could also prove significant in other organs. As such, they represent a new treatment target — both in cancer prevention and regenerative medicine.
Story Source:
Materials provided by Charité – Universitätsmedizin Berlin. Note: Content may be edited for style and length.

Read more →

Multiple treatments to slow age-related muscle wasting

Everyone wants to stay fit and healthy as they grow old. But as we age, our body degrades, our muscles shrink and strength declines. Some older people suffer from excessive muscle loss, a condition known as sarcopenia. University of Basel researchers show that a combination therapy could delay the onset of sarcopenia.
We now live longer than at any point in human history, but to enjoy those extra years, we need to remain healthy, mobile and independent. With age, however, our muscles inevitably lose mass and strength. This age-related muscle loss puts an end to an autonomous lifestyle for many elderly people, who must then rely on family or the healthcare system for daily support.
Slowing age-related muscle loss
“Age-related muscle decline already occurs in our thirties but begins to accelerate at around 60. By age 80, we have lost about a third of our muscle mass,” says Dr. Daniel Ham, one of the lead authors of the study now published in “Nature Communications”. “Although this aging process cannot be stopped, it is possible to slow it down or counteract it, for example through exercise.”
Researchers led by Professor Markus Rüegg at the Biozentrum of the University of Basel have demonstrated in mice that both calorie restriction and the drug rapamycin have a positive effect on aging skeletal muscle. “If we can understand what happens in the muscle as we age, perhaps we can design treatments to counteract muscle aging and prevent sarcopenia.”
“Both calorie restriction and rapamycin have been proposed as anti-aging interventions, but we didn’t expect the two treatments to provide additive benefits,” explains Dr. Nitish Mittal, another lead author of the study. Previously, it was thought that moderate fasting and rapamycin represent different means of achieving the same goal, namely suppression of the protein complex mTORC1, which accelerates aging when overactive.
Beneficial effects enhanced with combined treatment
“Contrary to our expectations, the treatments do not redundantly converge at mTORC1,” emphasizes Ham. “While we could understand that calorie restriction would have beneficial effects beyond mTORC1 suppression, it was incredibly surprising to us that rapamycin, an mTORC1 inhibitor, further slowed muscle aging in calorie restricted mice, where mTORC1-activating nutrients are available for just a few hours each day.” In calorie-restricted mice treated with rapamycin, the beneficial effects were therefore additive, with mice displaying significantly better muscle function than mice receiving either treatment alone. “Compared to their peers, treated mice are more active and physically capable because their muscles remain healthy,” says Ham.
Healthy muscles for longer independence
“The health of our muscle really is wealth. Beyond physical function, muscles are essential for whole-body metabolism and the proper functioning of many organs,” says Mittal. The positive impact of calorie-restricted diets and rapamycin on muscle aging leads to the intriguing question of whether elderly people suffering from sarcopenia can profit from a combined therapy consisting of an mTORC1 inhibitor, a calorie restriction-mimicking drug and perhaps exercise.
“Strong and healthy muscles provide many benefits for elderly people, in fact for all of us,” says Ham. “We can live an active and independent life for longer, and enjoy activities such as hiking, traveling or taking care of the grandkids.” This plays a major role in life quality and satisfaction in old age and also relieves the health care burden.
Story Source:
Materials provided by University of Basel. Note: Content may be edited for style and length.

Read more →

Stop the clocks: Brisk walking may slow biological aging process, study shows

A new study of genetic data published today (Wednesday) of more than 400,000 UK adults has revealed a clear link between walking pace and a genetic marker of biological age.
Confirming a causal link between walking pace and leucocyte telomere length (LTL) — an indicator of biological age — the Leicester-based team of researchers estimate that a lifetime of brisk walking could lead to the equivalent of 16 years younger biological age by midlife.
Researchers from the University of Leicester at the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre studied genetic data from 405,981 middle-aged UK Biobank participants and found that a faster walking pace, independent of the amount of physical activity, was associated with longer telomere.
Telomeres are the ‘caps’ at the end of each chromosome, and hold repetitive sequences of non-coding DNA that protect the chromosome from damage, similar to the way the cap at the end of a shoelace stops it from unravelling.
Each time a cell divides, these telomeres become shorter — until a point where they become so short that the cell can no longer divide, known as ‘replicative senescence’. Therefore, scientists consider LTL a strong marker for ‘biological age’, independent from when an individual was born.
Although the relationship between telomere length and disease is not fully understood, the build-up of these senescent cells is believed to contribute to a range of symptoms we associate with aging, such as frailty and age-related diseases.

Read more →

Arm movement and running speed: Is the partnership overrated?

New research into human speed from a team at SMU (Southern Methodist University,) and West Chester University suggests that athletes who performed short sprints with their arms closed across their chests were nearly as fast as when they sprinted with their normal arm swing.
The findings, published in the journal Gait & Posture, offer additional fundamental insights regarding limb synchronization during sprint performance.
“Our findings suggest the classic view that arm swing directly drives leg motion to affect performance is not well-supported,” said Peter Weyand, an expert in human speed who leads SMU’s Locomotor Performance Lab.
The coauthors of the research are lead author Lance C. Brooks, a doctoral student studying with Weyand in the Department of Applied Physiology & Wellness; Weyand, who is Glenn Simmons Endowed Professor of Applied Physiology and Biomechanics in the Department of Applied Physiology & Wellness in SMU’s Annette Caldwell Simmons School of Education & Human Development; and Kenneth P. Clark, an associate professor in the Department of Kinesiology at West Chester University. Brooks previously studied under Clark at West Chester University as he completed his master’s degree in exercise science and biomechanics.
The study examined the velocity of participants first sprinting 30 meters with regular arm motion, then again with restricted arm motion. When study participants sprinted with restricted arm motion, their 30-meter sprint time slowed down by only 0.08 seconds on average, a 1.6 percent difference from when the participants sprinted while moving their arms.
“We were surprised by the small magnitude of difference between the two experimental conditions. It is generally believed that the arms substantially influence the movement of the legs, and therefore running speed, which clearly is not the case,” Brooks said.
“When the athletes sprinted with restricted arm swing, the torso rotated back and forth appreciably more than normal to counterbalance the swinging legs,” Brooks added. “We believe that this extra torso rotation effectively compensated for arm swing to help maintain the body’s forward-facing orientation and the overall mechanics needed for speed.”
The study’s results strongly suggest that human runners use arm motion to prevent the body from rotating away from its forward-facing orientation.
“The compensatory torso twisting movements we observed during arm motion restriction indicate that runners swing their arms as the simplest and most natural strategy to prevent undesirable bodily rotations,” Clark said.
Do the team’s findings mean we will see less arm-swinging among sprinters in competitive sprinting? Probably not, as the difference in timed results is often razor-thin in timed competitions. The researchers point to the results of the 2020 Olympics Men’s 100-meter final, where the difference between the Gold and Bronze medal was only 0.09 seconds.
But the study’s findings are still an important step toward better understanding the influence of arm rotation on sprint performance.
“Virtually all runners choose to swing their arms to maintain a forward-facing position,” Weyand said. “The classic studies on the ‘why’ of arm motion during human locomotion are 40 or more years old and focused primarily on walking and jogging. So, performance effects were largely unknown,” he said.
Story Source:
Materials provided by Southern Methodist University. Note: Content may be edited for style and length.

Read more →

Everyday plastic products release trillions of microscopic particles into water

Plastics surround us, whether it’s the grocery bags we use at the supermarket or household items such as shampoo and detergent bottles. Plastics don’t exist only as large objects, but also as microscopic particles that are released from these larger products. These microscopic plastics can end up in the environment, and they can be ingested into our bodies.
Now, researchers at the National Institute of Standards and Technology (NIST) have analyzed a couple of widely used consumer products to better understand these microscopic plastics. They found that when the plastic products are exposed to hot water, they release trillions of nanoparticles per liter into the water.
The NIST researchers published their findings in the scientific journal Environmental Science and Technology.
“The main takeaway here is that there are plastic particles wherever we look. There are a lot of them. Trillions per liter. We don’t know if those have bad health effects on people or animals. We just have a high confidence that they’re there,” said NIST chemist Christopher Zangmeister.
There are many different types of plastic materials, but they are all made up of polymers, natural or human-made substances composed of large molecules linked together. Scientists have found microscopic particles from these larger plastics in the oceans and many other environments. Researchers categorize them into two groups: micro- and nanoplastics.
Microplastics are generally considered smaller than 5 millimeters in length and could be seen by the naked eye, while nanoplastics are smaller than one millionth of a meter (one micrometer) and most can’t even be seen with a standard microscope. Recent studies have shown some consumer products that hold liquids or interact with them, such as polypropylene (PP) baby bottles and nylon plastic tea bags, release these plastic particles into the surrounding water.

Read more →

A new pathway to shrink cancerous tumors through body's immune cells

Cancer researchers at the Case Western Reserve University School of Medicine say they have successfully suppressed the growth of some solid tumors in research models by manipulating immune cells known as a macrophages.
The researchers say this discovery is significant as many solid tumor cancers like lung cancer are difficult to treat. According to the National Cancer Institute, breast, lung, prostate and colorectal cancers — which are all solid tumor cancers-account for almost half of all new cancer cases in the United States.
In this new research, the scientists discovered that altering the macrophage metabolism — and in doing so influence their relationship with T cells — suppressed the tumor’s growth. The result was a significant reduction in overall tumor size in some mouse models.
“The race to find a cure for cancer never stops,” said Stanley Huang, an assistant professor of immunology in the Department of Pathology at the School of Medicine, who led the research. “Our research creates a pathway to a [potential] new form of cancer treatment for those with solid tumor cancers.”
The study appeared recently in the journal, Nature Immunology.
T cells and macrophages
Generally, the body’s immune response to disease involves mobilizing white blood cells that attack invaders like germs and bacteria.

Read more →

Ethical communication in the age of information

Since its inception, the Internet has fundamentally changed all parts of human society for both good and ill, and medical research is no exception. The fast pace of change enabled by digital technologies means that ethical guidelines may not address all the issues that arise in modern research. To help solve this problem, researchers from Osaka University performed an ethical analysis based on the eight ethical principles for clinical research and they proposed an ethical framework and practical guidance for communicating with research participants through the Internet.
The ability to recruit study participants regardless of geography is a major advantage of electronic communications, such as for studies of rare diseases, where it is often difficult to find enough participants in a defined geographic area to ensure scientific validity. However, the ease and scale of electronic communications has also led to serious problems such as violations of privacy, duplicate registrations, and misinformation that existing ethical guidelines didn’t anticipate.
“Currently, there are no comprehensive rules or guidelines for the various electronic methods used to communicate with research participants,” says Atsushi Kogetsu, lead author of the study, “and that includes methods for collecting electronic informed consent and online recruitment.” Hence, the authors performed an ethical analysis to determine what the issues are and how they relate to each other.
The analysis is based on the Emanuel framework, which consists of eight ethical principles for clinical research: collaborative partnership, social value, scientific validity, fair participant selection, favorable risk-benefit ratio, independent review, informed consent, and respect for participants. For instance, the researchers found that although there are many advantages to online communications, it is important to consider how patient access to the Internet varies according to circumstances and culture, which could affect participant recruitment, leading to selection bias.
“We also need to be careful how we present information to study participants,” says Kazuto Kato, co-author of the study. “It’s important to remember that the lack of nonverbal information when using some online tools can lead to miscommunication. We need to make sure that information is complete and accurate but not overwhelming.”
The proposed framework covers both the specific processes involved in medical research (from research design to the dissemination of results) and three overarching perspectives (access to research, community involvement, and independent review). It provides the practical steps independent reviewers, funding agencies, researchers, and patient partners can use to ensure all ethical guidelines are followed. The researchers believe the results of this study and its framework will improve future practice in medical research using the Internet.
Story Source:
Materials provided by Osaka University. Note: Content may be edited for style and length.

Read more →

Study Raises Questions About Popular Genetic Test for ‘Abnormal’ Embryos

The test leads people undergoing in vitro fertilization to discard thousands of embryos each year. The new research found implanting some “abnormal” embryos resulted in healthy live births.When they began their first two rounds of in vitro fertilization in 2015, Anna Dahlquist and her husband, Brian, took a common genetic test to determine the condition of the embryos they had created. The results were devastating: All 13 were “abnormal.”The embryos sat frozen at their fertility clinic in Seattle for six years as the couple underwent round after grueling round of unsuccessful I.V.F. After three years, they had a healthy daughter, using an embryo that they had decided not to test. Then, last year, they went to a new clinic — one that has questioned the reliability of the popular genetic test they took. The clinic implanted a round of the couple’s irregular embryos — two embryos with one chromosomal error and one with two errors. Last month, Ms. Dahlquist gave birth to a healthy baby boy.“I was 39 when I made his embryo,” Ms. Dahlquist said. “And I was 46 when I became pregnant with him. That’s a long time and a lot of valuable years in both my child’s upbringing and my life.”The genetic test, called preimplantation genetic testing for aneuploidy, or PGT-A, has, over the last two decades, become a standard add-on to already pricey I.V.F. procedures. But the test, which can cost anywhere from $4,000 to $10,000, has become controversial over the years as studies have cast doubt on whether it increases birthrates from I.V.F. at all. A growing number of scientists have questioned the widespread use of the test, which leads to tens of thousands of discarded embryos per year and causes many women to believe they may not be able to carry biological children.A new study published last week details 50 patients who underwent transfers of abnormal embryos at the Center for Human Reproduction in New York City. (The Dahlquists had their abnormal embryos transferred to this clinic, since their local clinic would not implant them.) The study reported eight births after 57 transfer cycles of embryos with abnormal genetic testing results since 2015. Seven of the babies were born healthy. The average age of the women in the study was 41 years old.The study is a follow-up to a 2015 study also led by the center that first showed that selected abnormal embryos could still be viable. Since then, other fertility clinics worldwide have also started to transfer such embryos.The research was funded by the clinic and by the Foundation for Reproductive Medicine, a nonprofit research organization also based in New York.The new study “supports concerns that I and others have had for several years now about the accuracy of these tests,” Josephine Johnston, a bioethicist and director of research at the Hastings Center who was not involved in the research, said by email. “The study strengthens the argument that PGT-A tests have been prematurely incorporated into fertility medicine and strongly suggests that these tests will have led patients to discard potentially viable embryos.”But the new study also shows the limitations of transferring such embryos. A vast majority of the 144 embryos transferred by the group had only one or two chromosomal abnormalities, but the transfers led to 11 miscarriages in addition to the eight live births.“There’s a lot of miscarriages in that ratio,” said Laura Hercher, director of student research at the Sarah Lawrence College genetic counseling program.The PGT-A test is used to screen for aneuploidy, which is when an improper number of chromosomes — either too few or too many — is detected in sampled cells. An abnormal number of chromosomes can, in serious cases, lead to genetic disabilities, like Down syndrome. More often, the wrong number of chromosomes can lead to failed pregnancies, either by preventing embryos from implanting or by causing miscarriages.But the problem with PGT-A, the authors of the study argue, is that it provides an incomplete picture that is often interpreted as a very definitive result. The test relies on sampling a handful of cells from the outer shell of the developing embryo and testing to see if each one has 23 pairs of chromosomes.“The point of PGT was to select embryos that would give somebody a better chance of achieving pregnancy,” said Dr. David Barad, an OB-GYN at the Center for Human Reproduction and a co-author of the study. “But doing genetic testing doesn’t make embryos better, it just kind of gives us some idea of who they are.”Though moving ahead with using these embryos with abnormalities may come with some risk, the authors of the new study, all of whom were connected to the clinic doing the transfers, argue that viable embryos are currently being disregarded, leaving many women to believe they have no other options to achieve a pregnancy.“The miscarriage rate is roughly what one expects at such advanced age,” Dr. Norbert Gleicher, director of the clinic and a co-author of the study, said by email. He added: “Ask women what they prefer. A risk of miscarriage or no chance of having a baby at all. The answer will be clear.”In one of the pregnancies in the study, the fetus was diagnosed with a heart defect in utero. The parents moved forward and had a live birth. After having surgery as a newborn, the baby is reportedly healthy. Dr. Gleicher said there was “no known connection whatsoever” between the birth defect and the chromosomal error.A bigger study of outcomes would make clearer whether there is a risk of birth defects, Ms. Hercher said. But this outcome also speaks to the complex level of uncertainty that fertility providers will have to face — and properly educate their patients about — when it comes to the potential risks involved with using these embryos.“We don’t really know what to tell them about the long term potential consequences to a child that’s born,” Ms. Hercher said. “Will there be an increased number of birth defects? Will we find that they have problems down the road? There’s a lot of ‘I don’t knows.’”Irregular numbers of chromosomes are surprisingly common, especially as women get older. For women over 35, there’s roughly a 50 percent incidence of aneuploidy in embryos produced during I.V.F. that increases with age. As the fertilized egg divides and multiplies into cells, errors that occur down the line can be replicated. But the normal cells might have a competitive advantage over the abnormal cells, leading the vast majority of the cells in the embryo to still have the correct number of chromosomes. Or some of those incorrect cells may eventually self-correct.Either way, the potential for this patchwork of cells means that any one picture of the embryo will be limited. A normal test result could miss irregular cells elsewhere, and one cell with the wrong number of chromosomes is enough to turn up abnormal results. By sampling just a small subset of cells at a very early stage in embryo development, PGT-A may cause some fertility clinics, wary of taking risks, to reject embryos that could lead to healthy pregnancies.False positives are also a problem for women who don’t undergo I.V.F. On Tuesday, the Food and Drug Administration warned that noninvasive prenatal tests, which look for signs of genetic abnormalities in the fetus, could lead patients to make decisions about their pregnancies based on incorrect information. Some researchers argue that PGT-A may still be useful for some people. For younger patients who produce more eggs, the test can help rank which embryos have the highest likelihood of succeeding, minimizing the number of procedures they have to undergo and pay for.But the Dahlquists, who were told that the “abnormal” embryos they produced in their first two cycles of I.V.F. could not be used, believe more nuance needs to be communicated to patients so they can be empowered to weigh the risks and make informed decisions.The fact that their fertility clinic would not allow potentially viable embryos to be used and forced them to wait six years to use them made her feel powerless, Ms. Dahlquist said. Few clinics will agree to transfer such embryos, and, at the time they took the test, the couple didn’t even know that was a possibility.“I just feel like it’s unfair,” she added. “They really are ruining a lot of people’s chances.”

Read more →